Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas

4 May 2018

Abstract excerpt

Importance: Patients with advanced soft-tissue sarcomas (STS) have a median overall survival of less than 18 months. Identification of molecular abnormalities for which targeted therapies are available or can be developed is critical for improving patient outcomes. Objective: To characterize targetable genomic alterations (GAs) in patients with STS. Design, Setting, and Participants: This cross-sectional study of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrointestinal Tumor Research and Treatment
Share to Neurofibromatosis and Schwannoma Cases
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29801054
DOI: 10.1001/jamaoncol.2018.0723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targetable Alterations in Adult Patients With Soft-Tissue SarcomasPMID 29801054Read ↗

Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.Semantic proximity Read ↗

The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.Semantic proximity Read ↗

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic ArsenalSemantic proximity Read ↗

Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.Semantic proximity Read ↗

A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosisSemantic proximity Read ↗

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsSemantic proximity Read ↗

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsSemantic proximity Read ↗

Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targetsSemantic proximity Read ↗

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.Semantic proximity Read ↗

Precision Oncology in Sarcomas: Divide and ConquerSemantic proximity Read ↗

Transcriptomic-Based Classification Identifies Prognostic Subtypes and Therapeutic Strategies in Soft Tissue SarcomasSemantic proximity Read ↗

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.